The present invention relates to prosthetic stents. In particular, the present invention relates to stents having helical elements and to methods for manufacturing the stents of the present invention.
Stents are prosthetic devices that are implanted in the lumen of a vessel inside the body to provide support for the vessel's wall. Structural support from stents is particularly important in angioplasty procedures. Typically, stents are implanted within a vessel system to reinforce vessels that are partially occluded, collapsing, weakened, or abnormally dilated. More generally, stents can be used inside any physiological conduit or duct including, for example, arteries, veins, bile ducts, the urinary tract, alimentary tracts, the tracheobronchial tree, a cerebral aqueduct or the genitourinary system. Stents may be used in both humans and animals.
There are typically two types of stents: self expanding stents and balloon expandable stents. Self expanding stents automatically expand once they are released and assume a deployed, expanded state. A balloon expandable stent is expanded using an inflatable balloon catheter. The balloon is inflated to plastically deform the stent. Balloon expandable stents may be implanted by mounting the stent in an unexpanded or crimped state on a balloon segment of a catheter. The catheter, after having the crimped stent placed thereon, is inserted through a puncture in a vessel wall and moved through the vessel until it is positioned in the portion of the vessel that is in need of repair. The stent is then expanded by inflating the balloon catheter against the inside wall of the vessel. Specifically, the stent is plastically deformed by inflating the balloon so that the diameter of the stent is increased and remains at an increased state. In some situations, the vessel in which the stent is implanted may be dilated by the stent itself when the stent is expanded.
The Palmaz-Schatz™ stent, which is disclosed in the Handbook of Coronary Stents by Patrick W. Serruys et al. (Martin Dunitz, LTD 1998), is an example of a balloon expandable stent that had been implanted in hundreds of thousands of patients. The Palmaz-Schatz™ stent, like other known stents, has certain limitations. These include, but are not limited to: (i) low stent-to-vessel ratio uniformity, (ii) comparative rigidity of the stent in a crimped as well as deployed state, and (iii) limited flexibility making delivery and placement in narrow vessels difficult. Stent-to-vessel ratio generally refers to the degree that the vessel wall is supported by the stent in its expanded state and preferably should be uniform throughout the length of the stent. Furthermore because the Palmaz-Schatz™ stent consists of one or more bridges that connect a number of consecutively slotted tubes, there are a number of bare areas in the vessel after the expansion of the stent. These shortfalls are common to many stents. Id. at 36.
The present invention is directed to expandable stents that have relatively uniform stent-to-vessel ratios when expanded and other desirable properties, as well as methods for making these stents. The stents of the present invention comprise a generally cylindrically shaped main body having a plurality of expandable helical segments. The main body is comprised of a plurality of cylindrical main body elements that are joined together by the helical segments. The cylindrical elements have cylindrical axes that are collinear with the cylindrical axis of the main body. The cylindrical elements are formed from a plurality of circumferential elements that are joined together by the expandable helical segments. In some embodiments, the stent may comprise endzones that straddle the main body.
In one embodiment of the present invention, the stent may comprise a first non-helical endzone and a second non-helical endzone that straddle the main body. The main body is generally cylindrically shaped and has a cylindrical axis. A plurality of adjacent main body cylindrical elements are connected together to form the main body of the stent. Each main body cylindrical element may be comprised of a plurality of expandable first and second circumferential elements. In some embodiments, the second circumferential elements have a circumferential dimension less than the circumferential dimension of the first circumferential elements. In yet other embodiments, the first and second circumferential elements have the same circumferential dimensions and are substantially identical except that, with respect to the cylindrical axis of the stent, they are oriented differently. Each second circumferential segment in each main body cylindrical element is connected to two first circumferential segments. In addition, each second circumferential segment in each main body cylindrical element is connected to a second circumferential segment in an adjoining main body cylindrical element thereby forming a plurality of helixes in the main body of the stent.
In one embodiment, the main body may be comprised of a plurality of first helical segments each having a substantially identical first pitch and a plurality of second helical segments, each having a substantially identical second pitch. The first and second pitches are generally different. In at least one embodiment, the second pitch is twice that of the first, and at least one first helical segment crosses one of the second helical segments.
The stents of the present invention may be manufactured from a tubular member by removing material from the tube to form a first endzone region, a second endzone region, and a middle region. By removing material from the middle region a plurality of parallel helical segments will remain and a plurality of circumferential segments will remain connecting the helical segments. Alternatively, the stent may be formed from a tube by removing material such that at least two sets of helical segments remain with each set having a different pitch.
The present invention is directed to an expandable stent, as well as a method of manufacturing the stent. In one embodiment, as is shown in
The stent may also have a first endzone 10 and a second endzone 20 that straddle the body section 11. In some embodiments, such as the one shown in
The main body 11, shown in
As is shown in
The first circumferential segment 50 may be an expandable segment formed from plurality of segments joined together to form a pattern. The pattern, such as the one shown in the
The first circumferential elements 50 may have a filament width 420 (see
In the embodiment shown in
The second circumferential element 60, which may be joined together in a helical pattern to form one or more helical segments 30 or 40, may also take numerous forms, in addition to the form shown in
As is shown in
As is shown in
Likewise, the helical segments 200, 210 are circumferentially expandable and may be comprised of other circumferential elements 50 that are in turn comprised of linear 320 and/or curved segments 328 (see
Some, but not all embodiments, of the present invention may employ endzones 10 and 20. (See
The endzones 10 and 20 may take numerous forms. In some embodiments, the endzones may be comprised of one or more rings 17. (See
In the embodiment shown in
The stent of the present invention may, after insertion into a vessel, be expanded such that it plastically deforms from the unexpanded state to an expanded state having a diameter increase of about 400 to 500%, which results in a larger circumference 105. (See
While endzones 10 and 20 may be used to provide square edge, not all stents according to the present invention require endzones.
Adjacent cylindrical elements 100 are joined together by connecting first circumferential elements 50′ in each cylindrical element 100 with first circumferential elements 50′ in an adjacent cylindrical element 100, such that the first circumferential elements 50′ in adjacent cylindrical elements 100 form helixes through the stent and such that second circumferential elements form helixes through the stent having an angle .theta. relative to the axis 5. In some embodiments, a connecting segment 250 (see
The above description of the stent of the present invention is illustrative and not exhaustive. Various modifications may be made to the stent to change its overall characteristics without deviating from the scope and spirit of the invention as defined by the claims. For example and without limitation, the increasing the length of the linear segments and or increasing the arc of the second circumferential elements 60 will decrease the amount of radial force required to expand each circular section and will increase flexibility. Increasing the angle .OMEGA. of the second circumferential element 60 will: (i) increase the amount of radial force required for expansion, (ii) increase surface area, and (iii) decrease flexibility. Likewise, various modifications may be made to the struts 15. (See
The stent of the present invention may be manufactured in numerous ways. The stent may be formed from a metallic tube by removing various portions of the tube's wall to form the patterns described herein. The resulting stent will thus be formed from a single contiguous piece of material, eliminating the need for connecting various segments together. Material from the tube wall may be removed using various techniques including laser (YAG laser for example), electrical discharge, chemical etching, metal cutting, a combination of these techniques, or other well known techniques. See e.g. U.S. Pat. Nos. 5,879,381 to Moriuchi et al. and 6,117,165 to Becker, which are hereby incorporated in their entirety by reference. Forming stents in this manner allows for creation of a substantially stress-free structure where the helical segments are integral with the circumferential elements. In one embodiment, the tube from which the stent is formed may have an internal diameter of about 3.0 mm, a wall thickness of about 1.0 mm and a length of about 30 mm. Tubes having other dimensions may be used. In particular, the length may be adapted to that of the diseased part of the lumen in which the stent is to be placed. This may avoid using separate stents to cover the total diseased area.
Those skilled in the art will recognize that the stent and manufacturing method described above are illustrative and not exhaustive of the present invention and that modifications and variations may be made without deviating from the scope and spirit of the invention as defined by the following claims.
Number | Date | Country | Kind |
---|---|---|---|
97201799 | Jun 1997 | EP | regional |
98201446 | May 1998 | EP | regional |
This application is a continuation of U.S. patent application Ser. No. 12/027,382, filed on Feb. 7, 2008, which application is a continuation of U.S. patent application Ser. No. 10/014,705, filed on Dec. 11, 2001, now issued U.S. Pat. No. 7,329,277, which application claims the benefit of U.S. Provisional Application No. 60/254,688, filed on Dec. 11, 2000, all of which are hereby incorporated in their entirety by reference. U.S. patent application Ser. No. 10/014,705 is also continuation-in-part of U.S. patent application Ser. No. 09/511,481, filed on Feb. 23, 2000, now U.S. Pat. No. 7,108,714, which is a continuation of U.S. patent application Ser. No. 09/094,402, filed Jun. 10, 1998, now U.S. Pat. No. 6,117,165, all of which are hereby incorporated in their entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
4464722 | Von Osten | Aug 1984 | A |
5102417 | Palmaz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5158548 | Lau et al. | Oct 1992 | A |
5217483 | Tower | Jun 1993 | A |
5226913 | Pinchuk | Jul 1993 | A |
5304200 | Spaulding | Apr 1994 | A |
5354308 | Simon et al. | Oct 1994 | A |
5356423 | Tihon et al. | Oct 1994 | A |
5370683 | Fontaine | Dec 1994 | A |
5421955 | Lau et al. | Jun 1995 | A |
5443498 | Fontaine | Aug 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5514154 | Lau et al. | May 1996 | A |
5527354 | Fontaine et al. | Jun 1996 | A |
5545210 | Hess et al. | Aug 1996 | A |
5549663 | Cottone, Jr. | Aug 1996 | A |
5591230 | Horn et al. | Jan 1997 | A |
5630829 | Lauterjung | May 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5716396 | Williams, Jr. | Feb 1998 | A |
5725572 | Lam et al. | Mar 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5741327 | Frantzen | Apr 1998 | A |
5755776 | Al-Saadon | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5800521 | Orth | Sep 1998 | A |
5810872 | Kanesaka et al. | Sep 1998 | A |
5824040 | Cox | Oct 1998 | A |
5824043 | Cottone, Jr. | Oct 1998 | A |
5843117 | Alt et al. | Dec 1998 | A |
5843120 | Israel et al. | Dec 1998 | A |
5843158 | Lenker et al. | Dec 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5843175 | Frantzen | Dec 1998 | A |
5846246 | Dirks et al. | Dec 1998 | A |
5855597 | Jayaraman | Jan 1999 | A |
5860999 | Schnepp-Pesch et al. | Jan 1999 | A |
5876449 | Starck et al. | Mar 1999 | A |
5879381 | Moriuchi et al. | Mar 1999 | A |
5882335 | Leone et al. | Mar 1999 | A |
5895406 | Gray et al. | Apr 1999 | A |
5902317 | Kleshinski et al. | May 1999 | A |
5911732 | Hojeibane | Jun 1999 | A |
5911754 | Kanesaka et al. | Jun 1999 | A |
5913897 | Corso et al. | Jun 1999 | A |
5925061 | Ogi et al. | Jul 1999 | A |
5928280 | Hansen et al. | Jul 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5938697 | Killion et al. | Aug 1999 | A |
5948016 | Jang | Sep 1999 | A |
5964798 | Imran | Oct 1999 | A |
5972018 | Israel et al. | Oct 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
6013854 | Moriuchi | Jan 2000 | A |
6017365 | Von Oepen | Jan 2000 | A |
6019789 | Dinh et al. | Feb 2000 | A |
6022370 | Tower | Feb 2000 | A |
6033433 | Ehr et al. | Mar 2000 | A |
6042597 | Kveen et al. | Mar 2000 | A |
6053940 | Wijay | Apr 2000 | A |
6059811 | Pinchasik et al. | May 2000 | A |
6083259 | Frantzen | Jul 2000 | A |
6099559 | Nolting | Aug 2000 | A |
6099561 | Alt | Aug 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6117165 | Becker | Sep 2000 | A |
6123721 | Jang | Sep 2000 | A |
6124523 | Banas | Sep 2000 | A |
6129755 | Mathis et al. | Oct 2000 | A |
6132460 | Thompson | Oct 2000 | A |
6132461 | Thompson | Oct 2000 | A |
6136023 | Boyle | Oct 2000 | A |
6171334 | Cox | Jan 2001 | B1 |
6174326 | Kitaoka et al. | Jan 2001 | B1 |
6179867 | Cox | Jan 2001 | B1 |
6190403 | Fischell et al. | Feb 2001 | B1 |
6200334 | Jang | Mar 2001 | B1 |
6200337 | Moriuchi et al. | Mar 2001 | B1 |
6203569 | Wijay | Mar 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6238409 | Hojeibane | May 2001 | B1 |
6241762 | Shanley | Jun 2001 | B1 |
6245101 | Drasler et al. | Jun 2001 | B1 |
6254628 | Wallace et al. | Jul 2001 | B1 |
6254632 | Wu et al. | Jul 2001 | B1 |
6261319 | Kveen | Jul 2001 | B1 |
6264689 | Colgan et al. | Jul 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6309414 | Rolando et al. | Oct 2001 | B1 |
6319277 | Rudnick et al. | Nov 2001 | B1 |
6331188 | Lau et al. | Dec 2001 | B1 |
6331189 | Wolinsky et al. | Dec 2001 | B1 |
6340366 | Wijay | Jan 2002 | B2 |
6348065 | Brown et al. | Feb 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6355057 | DeMarais et al. | Mar 2002 | B1 |
6364904 | Smith | Apr 2002 | B1 |
6395020 | Ley et al. | May 2002 | B1 |
6398805 | Alt | Jun 2002 | B1 |
6423091 | Hojeibane | Jul 2002 | B1 |
6432132 | Cottone et al. | Aug 2002 | B1 |
6443982 | Israel et al. | Sep 2002 | B1 |
6461381 | Israel et al. | Oct 2002 | B2 |
6464722 | Israel et al. | Oct 2002 | B2 |
6485508 | McGuinness | Nov 2002 | B1 |
6506211 | Skubitz et al. | Jan 2003 | B1 |
6508834 | Pinchasik et al. | Jan 2003 | B1 |
6533809 | von Oepen | Mar 2003 | B2 |
6551350 | Thornton et al. | Apr 2003 | B1 |
6569193 | Cox et al. | May 2003 | B1 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6582461 | Burmeister et al. | Jun 2003 | B1 |
6589276 | Pinchasik et al. | Jul 2003 | B2 |
6602285 | Von Oepen et al. | Aug 2003 | B1 |
6610086 | Kock et al. | Aug 2003 | B1 |
6620201 | Nadal | Sep 2003 | B1 |
6635084 | Israel et al. | Oct 2003 | B2 |
6652579 | Cox | Nov 2003 | B1 |
6682554 | Von Oepen et al. | Jan 2004 | B2 |
6730116 | Wolinsky | May 2004 | B1 |
6730117 | Tseng | May 2004 | B1 |
6736844 | Glatt | May 2004 | B1 |
6776793 | Brown et al. | Aug 2004 | B2 |
6818014 | Brown et al. | Nov 2004 | B2 |
6821292 | Pazienza et al. | Nov 2004 | B2 |
6875228 | Pinchasik et al. | Apr 2005 | B2 |
6929660 | Ainsworth et al. | Aug 2005 | B1 |
6962203 | Funchess | Nov 2005 | B2 |
6974475 | Wall | Dec 2005 | B1 |
6981986 | Brown et al. | Jan 2006 | B1 |
7204848 | Brown et al. | Apr 2007 | B1 |
7329277 | Addonizio et al. | Feb 2008 | B2 |
7404823 | Gregorich et al. | Jul 2008 | B2 |
7682384 | Addonizio et al. | Mar 2010 | B2 |
20010029397 | Thompson | Oct 2001 | A1 |
20010056298 | Brown et al. | Dec 2001 | A1 |
20020095208 | Gregorich et al. | Jul 2002 | A1 |
20020116044 | Cottone et al. | Aug 2002 | A1 |
20030225448 | Gerberding | Dec 2003 | A1 |
20040243216 | Gregorich | Dec 2004 | A1 |
20050049687 | Yang et al. | Mar 2005 | A1 |
20070073384 | Brown et al. | Mar 2007 | A1 |
20070100434 | Gregorich et al. | May 2007 | A1 |
20080065195 | Brown et al. | Mar 2008 | A1 |
20090024207 | Addonizio et al. | Jan 2009 | A1 |
Number | Date | Country |
---|---|---|
29702671 | May 1997 | DE |
19717475 | Sep 1998 | DE |
0565251 | Oct 1993 | EP |
0645125 | Mar 1995 | EP |
0686379 | Dec 1995 | EP |
0734698 | Oct 1996 | EP |
0800800 | Oct 1997 | EP |
0801934 | Oct 1997 | EP |
876806 | Nov 1998 | EP |
0876806 | Nov 1998 | EP |
0884029 | Dec 1998 | EP |
0945107 | Sep 1999 | EP |
945107 | Sep 1999 | EP |
0968689 | Jan 2000 | EP |
0970664 | Jan 2000 | EP |
0983753 | Mar 2000 | EP |
1008329 | Jun 2000 | EP |
1025812 | Sep 2000 | EP |
1123065 | Nov 2006 | EP |
1852089 | Nov 2007 | EP |
2204142 | Jul 2010 | EP |
2758253 | Jul 1998 | FR |
2281865 | Mar 1995 | GB |
9417754 | Aug 1994 | WO |
9526695 | Oct 1995 | WO |
9626689 | Sep 1996 | WO |
9721399 | Jun 1997 | WO |
9726840 | Jul 1997 | WO |
9732544 | Sep 1997 | WO |
9740780 | Nov 1997 | WO |
9820810 | May 1998 | WO |
9830173 | Jul 1998 | WO |
9840035 | Sep 1998 | WO |
9856312 | Dec 1998 | WO |
9912495 | Mar 1999 | WO |
9939660 | Aug 1999 | WO |
9949810 | Oct 1999 | WO |
0013611 | Mar 2000 | WO |
0030563 | Jun 2000 | WO |
0045742 | Aug 2000 | WO |
0071053 | Nov 2000 | WO |
0158384 | Aug 2001 | WO |
0189421 | Nov 2001 | WO |
Entry |
---|
Notice of Opposition dated Jul. 28, 2011 re EP 1341482. |
Notice of Opposition dated Aug. 5, 2011 re EP 1341482. |
Simon H. Stertzer et al., AVE GFX Stent, Handbook of Coronary Stents, Second Edition, 1997, pp. 45-54, Martin Dunitz Ltd., The Livery House, London, United Kingdom. |
Richard A. Schatz et al., Handbook of Coronary Stents, 1997, p. 24, Martin Dunitz Ltd., The Livery House, London, United Kingdom. |
Home Medical Devices Products and Medical Procedures Device Approvals and Clearances, Medical Devices, Dec. 1997 PMA Approvals, http://www.fda.gov/medicaldevices/productsandmedicalprocedures/ deviceapprovalsandclearances/pmaaprovals/ucm115816.htm, 5-pages. |
Jean Gregoire et al., Handbook of Coronary Stents, 1997, p. 72, Martin Dunitz Ltd., The Livery House, London, United Kingdom. |
Number | Date | Country | |
---|---|---|---|
20100211152 A1 | Aug 2010 | US |
Number | Date | Country | |
---|---|---|---|
60254688 | Dec 2000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12027382 | Feb 2008 | US |
Child | 12727567 | US | |
Parent | 10014705 | Dec 2001 | US |
Child | 12027382 | US | |
Parent | 09094402 | Jun 1998 | US |
Child | 09511481 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09511481 | Feb 2000 | US |
Child | 10014705 | US |